Skip to content
TrustList
Lionheart Ventures logo
Venture capital firm

Lionheart Ventures

A venture capital firm investing in artificial intelligence and mental health technology companies

Lionheart Ventures cover

TrustList summary

Lionheart Ventures is a venture capital firm focused on what it describes as the wise development of transformative technologies, with its main areas of investment being artificial intelligence and mental health technology. The firm says it backs founders developing AI technologies intended to defend and enhance human agency and resilience as the technology becomes more disruptive. In mental health, it invests in frontier approaches such as psychedelic medicine and neuromodulation, which it says can improve on current standards of care. Lionheart states that it looks for founders it considers ethical, developing technologies with the potential for meaningful impact alongside returns for its investors.

Summary written by TrustList from the business's own published information, Sep 2026.

Categories & features

Ask TrustList to introduce you to Lionheart Ventures

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Lionheart Ventures

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Lionheart Ventures.

Lionheart Ventures alternatives

Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Open-source blockchain with its own digital currency, digital assets, smart contracts and secure authentication

Global investment management company combining startup holdings with American stock market investments

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Life sciences venture fund backing biotech and biopharma companies from seed to later stage across three regions